Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions.
Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME; TAXUS II Study Group. Colombo A, et al. Among authors: drzewiecki j. Circulation. 2003 Aug 19;108(7):788-94. doi: 10.1161/01.CIR.0000086926.62288.A6. Epub 2003 Aug 4. Circulation. 2003. PMID: 12900339 Clinical Trial.
Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.
Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W, Bonnier J, Lablanche JM, Siminiak T, Nordrehaug J, Figulla H, Drzewiecki J, Banning A, Hauptmann K, Dudek D, Bruining N, Hamers R, Hoye A, Ligthart JM, Disco C, Koglin J, Russell ME, Colombo A; TAXUS II Study Group. Tanabe K, et al. Among authors: drzewiecki j. Circulation. 2005 Feb 22;111(7):900-5. doi: 10.1161/01.CIR.0000155607.54922.16. Epub 2005 Feb 14. Circulation. 2005. PMID: 15710761 Clinical Trial.
Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study.
Aoki J, Colombo A, Dudek D, Banning AP, Drzewiecki J, Zmudka K, Schiele F, Russell ME, Koglin J, Serruys PW; TAXUS II Study Group. Aoki J, et al. Among authors: drzewiecki j. Circulation. 2005 Dec 20;112(25):3876-83. doi: 10.1161/CIRCULATIONAHA.105.558601. Epub 2005 Dec 12. Circulation. 2005. PMID: 16344384 Clinical Trial.
Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions.
Silber S, Colombo A, Banning AP, Hauptmann K, Drzewiecki J, Grube E, Dudek D, Baim DS. Silber S, et al. Among authors: drzewiecki j. Circulation. 2009 Oct 13;120(15):1498-504. doi: 10.1161/CIRCULATIONAHA.109.849877. Epub 2009 Sep 28. Circulation. 2009. PMID: 19786634 Clinical Trial.
Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial.
Tsuchida K, Serruys PW, Bruining N, Dudek D, Drzewiecki J, Banning AP, Zmudka K, Schiele F, Zhou Z, Rademaker TA, van Es GA, Koglin J, Russell ME, Colombo A. Tsuchida K, et al. Among authors: drzewiecki j. Am J Cardiol. 2007 Mar 1;99(5):607-15. doi: 10.1016/j.amjcard.2006.09.107. Epub 2007 Jan 9. Am J Cardiol. 2007. PMID: 17317358 Clinical Trial.
Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study.
Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Baldus S, Hauptmann KE, Suttorp MJ, Drzewiecki J, Pieper M, Schultheiss HP, Mauri L. Fajadet J, et al. Among authors: drzewiecki j. EuroIntervention. 2010 Nov;6(5):562-7. doi: 10.4244/EIJV6I5A95. EuroIntervention. 2010. PMID: 21044908
A randomized comparison of elective high-pressure stenting with balloon angioplasty: six-month angiographic and two-year clinical follow-up. On behalf of AS (Angioplasty or Stent) trial investigators.
Witkowski A, Ruzyłło W, Gil R, Górecka B, Purzycki Z, Kośmider M, Poloński L, Lekston A, Gasior M, Zmudka K, Pieniazek P, Buszman P, Drzewiecki J, Ciećwierz D, Sadowski Z. Witkowski A, et al. Among authors: drzewiecki j. Am Heart J. 2000 Aug;140(2):264-71. doi: 10.1067/mhj.2000.107555. Am Heart J. 2000. PMID: 10925341 Clinical Trial.
Impact of diabetes on survival in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the POLISH STEMI registry.
De Luca G, Małek LA, Maciejewski P, Wasek W, Niewada M, Kamiński B, Drze wiecki J, Kośmider M, Kubica J, Ruzyłło W, Peruga JZ, Dudek D, Opolski G, Dobrzycki S, Gil RJ, Witkowski A; STEMI 2003 Registry Collaborators. De Luca G, et al. Atherosclerosis. 2010 Jun;210(2):516-20. doi: 10.1016/j.atherosclerosis.2009.12.012. Epub 2009 Dec 24. Atherosclerosis. 2010. PMID: 20083247
Influence of different antiplatelet treatment regimens for primary percutaneous coronary intervention on all-cause mortality.
Witkowski A, Maciejewski P, Wasek W, Malek LA, Niewada M, Kaminski B, Drzewiecki J, Kosmider M, Kubica J, Ruzyllo W, Peruga JZ, Dudek D, Opolski G, Dobrzycki S, Gil RJ; STEMI 2003 Registry Collaborators. Witkowski A, et al. Among authors: drzewiecki j. Eur Heart J. 2009 Jul;30(14):1736-43. doi: 10.1093/eurheartj/ehp114. Epub 2009 Apr 17. Eur Heart J. 2009. PMID: 19376786
85 results